Medikamentöse therapie der rheumatoiden arthritis

Translated title of the contribution: Current drug therapy in rheumatoid arthritis

T. A. Bongartz, O. Distler, U. Müller-Ladner

Research output: Contribution to journalArticle

Abstract

The introduction of novel, very effective drugs in the therapeutic armamentarium for the treatment of rheumatoid arthritis has not completely altered the general strategy but has led to a substantially improved situation for the affected patients. The current state-of-the-art includes non-steroidal antirheumatic drugs and low-dose steroids in combination with conventional disease-modifying drugs and biologics. However, owing to the complex character of the disease, a tight collaboration between the rheumatologist and the general practitioner is mandatory for the overall success of the long-term therapeutic regimen of the individual patient.

Original languageGerman
Pages (from-to)141-151
Number of pages11
JournalInternistische Praxis
Volume46
Issue number1
StatePublished - Mar 2006
Externally publishedYes

Fingerprint

Rheumatoid Arthritis
Drug Therapy
Antirheumatic Agents
Biological Products
Pharmaceutical Preparations
General Practitioners
Therapeutics
Steroids
Rheumatologists

Keywords

  • Biologics
  • Coxibs
  • NSAID
  • Rheumatoid arthritis
  • Steroids

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Bongartz, T. A., Distler, O., & Müller-Ladner, U. (2006). Medikamentöse therapie der rheumatoiden arthritis. Internistische Praxis, 46(1), 141-151.

Medikamentöse therapie der rheumatoiden arthritis. / Bongartz, T. A.; Distler, O.; Müller-Ladner, U.

In: Internistische Praxis, Vol. 46, No. 1, 03.2006, p. 141-151.

Research output: Contribution to journalArticle

Bongartz, TA, Distler, O & Müller-Ladner, U 2006, 'Medikamentöse therapie der rheumatoiden arthritis', Internistische Praxis, vol. 46, no. 1, pp. 141-151.
Bongartz TA, Distler O, Müller-Ladner U. Medikamentöse therapie der rheumatoiden arthritis. Internistische Praxis. 2006 Mar;46(1):141-151.
Bongartz, T. A. ; Distler, O. ; Müller-Ladner, U. / Medikamentöse therapie der rheumatoiden arthritis. In: Internistische Praxis. 2006 ; Vol. 46, No. 1. pp. 141-151.
@article{9a7b237fae20489791338b027cf90bce,
title = "Medikament{\"o}se therapie der rheumatoiden arthritis",
abstract = "The introduction of novel, very effective drugs in the therapeutic armamentarium for the treatment of rheumatoid arthritis has not completely altered the general strategy but has led to a substantially improved situation for the affected patients. The current state-of-the-art includes non-steroidal antirheumatic drugs and low-dose steroids in combination with conventional disease-modifying drugs and biologics. However, owing to the complex character of the disease, a tight collaboration between the rheumatologist and the general practitioner is mandatory for the overall success of the long-term therapeutic regimen of the individual patient.",
keywords = "Biologics, Coxibs, NSAID, Rheumatoid arthritis, Steroids",
author = "Bongartz, {T. A.} and O. Distler and U. M{\"u}ller-Ladner",
year = "2006",
month = "3",
language = "German",
volume = "46",
pages = "141--151",
journal = "Internistische Praxis",
issn = "0020-9570",
publisher = "Hans Marseille Verlag GmbH",
number = "1",

}

TY - JOUR

T1 - Medikamentöse therapie der rheumatoiden arthritis

AU - Bongartz, T. A.

AU - Distler, O.

AU - Müller-Ladner, U.

PY - 2006/3

Y1 - 2006/3

N2 - The introduction of novel, very effective drugs in the therapeutic armamentarium for the treatment of rheumatoid arthritis has not completely altered the general strategy but has led to a substantially improved situation for the affected patients. The current state-of-the-art includes non-steroidal antirheumatic drugs and low-dose steroids in combination with conventional disease-modifying drugs and biologics. However, owing to the complex character of the disease, a tight collaboration between the rheumatologist and the general practitioner is mandatory for the overall success of the long-term therapeutic regimen of the individual patient.

AB - The introduction of novel, very effective drugs in the therapeutic armamentarium for the treatment of rheumatoid arthritis has not completely altered the general strategy but has led to a substantially improved situation for the affected patients. The current state-of-the-art includes non-steroidal antirheumatic drugs and low-dose steroids in combination with conventional disease-modifying drugs and biologics. However, owing to the complex character of the disease, a tight collaboration between the rheumatologist and the general practitioner is mandatory for the overall success of the long-term therapeutic regimen of the individual patient.

KW - Biologics

KW - Coxibs

KW - NSAID

KW - Rheumatoid arthritis

KW - Steroids

UR - http://www.scopus.com/inward/record.url?scp=31544482115&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=31544482115&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:31544482115

VL - 46

SP - 141

EP - 151

JO - Internistische Praxis

JF - Internistische Praxis

SN - 0020-9570

IS - 1

ER -